In this Issue
Changes are affecting physicians and patients alike.
CHIEF MEDICAL EDITOR’S PAGE
By Steven D. Vold, MD
By Sarah Khodadadeh, MD
CLINICIAN SCIENTIST’S CORNER
A global perspective.
By Alfred Sommer, MD, MHS
By Sandra M. Johnson, MD, and Josh Nunn
Physicians must select which therapy is most appropriate for the stage of disease.
By Marlene R. Moster, MD, and Wanda D. Hu, MD
COVER STORIES: THE US GOVERNMENT’S IMPACT ON GLAUCOMA CARE
Practices face major changes.
By Cynthia Mattox, MD
The long, bumpy road to payment.
By Adam C. Reynolds, MD
The impact this year will be minimal for various reasons.
By William L. Rich III, MD
By Dan Eisenberg, MD; Mildred M. G. Olivier, MD; and Rohit Varma, MD, MPH
How can we control costs while providing quality care?
By Ronald L. Fellman, MD
Changes in reimbursement may be a driving force.
By Richard A. Lehrer, MD
Changes in methods of assessment should allow physicians to improve the care they provide.
By Paul P. Lee, MD, JD
The challenges are great but not insurmountable.
By Eric N. Brown, MD, PhD, and Rohit Krishna, MD
Treatments for some mental illnesses can cause or exacerbate glaucoma.
By Julia Song, MD
Preparing for the psychological and financial challenges that ensue.
By Donna W. Howell, JD, LLM in Tax
Entry Guidelines for GT’s Film Festival
Glaucoma Today invites glaucoma surgeons and clinicians to enter the 2014 Glaucoma Today Film Festival.